Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.
NCT ID: NCT04479280
Last Updated: 2020-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2020-07-20
2020-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of CRP, Ferritine and D-Dimer in Covid-19 Patients Admitted To Respiratory ICU in Assuit University Hospitals
NCT05102695
Non-invasive Predictors of ICU Admission and Mortality in Initially Asymptomatic COVID-19 Patients
NCT05298852
Characteristics of Critically Ill COVID 19 Patients
NCT04465058
Sepsis in ICU:Causes and Outcomes in Diabetics and Non Diabetics
NCT05914480
D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients
NCT05279469
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Covid19 positive patients
Sonclot Coagulation and platelet function Analyzer SCP1, Sienco, USA
studying coagulation disorders in COVID19 critically ill patients
Covid19 negative patients
Sonclot Coagulation and platelet function Analyzer SCP1, Sienco, USA
studying coagulation disorders in COVID19 critically ill patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sonclot Coagulation and platelet function Analyzer SCP1, Sienco, USA
studying coagulation disorders in COVID19 critically ill patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Azza Abdelaal
lecturer of clinical pathology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17300446
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.